Buy 2 Get 1 Free
Blend BPC-157 5mg with Thymosin Beta 4 (TB500) 5mg

Blend BPC-157 5mg with Thymosin Beta 4 (TB500) 5mg

$58.78 $146.95Save 60%
Quality Icon
  • Free Priority Shipping
  • Orders over $75
  • Quality Icon
  • Rewards Icon
  • 3rd Party Tested

Buy Blend BPC-157 5MG with Thymosin Beta 4 (TB500) 5MG:

Unit Size 10 mg/vial
Unit Quantity 1 vial
Purity (Mass Spectrometry and UV) 99.49%
Nominal Target: 5 mg BPC-157 + 5 mg Thymosin Beta 4 (TB500)
Sequence (BPC-157) H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH
Sequence (TB500) Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
Molecular Formula (BPC-157) C62H98N16O22
Molecular Formula (TB500) C212H350N56O78S
Appearance Lyophilized White Powder
Source Chemical Synthesis
Storage Lyophilized Blend BPC-157 5MG with Thymosin Beta 4 (TB500) 5MG is stable
at room temperature for 90 days, however it is best to store in a freezer
at -20°C for any extended period of time.
Terms The products we offer are intended for laboratory
research use only. Please familiarize yourself with
our terms of service prior to ordering.
COA Verification Verify this COA on Freedom Diagnostics →

Blend BPC-157 5mg with Thymosin Beta 4 (TB500) 5mg

All content and product information provided on this website are for informational and educational research purposes only. This product is not intended for human consumption, diagnostic use, or therapeutic use.
View Research Overview & References

This blend pairs BPC-157, a 15-residue pentadecapeptide, with the considerably larger 43-residue Thymosin Beta 4 (TB500), supplied together as a single lyophilized formulation for in vitro laboratory research.

Thymosin Beta 4 Actin-Sequestering Mechanism

Thymosin Beta 4 functions as the principal G-actin sequestering peptide in the cytoplasm, binding monomeric actin in a 1:1 complex that inhibits its polymerization into filaments, a mechanism central to laboratory research on cell motility and differentiation.1

Thymosin Beta 4 Tissue Distribution Research

Immunolocalization studies using autoptic tissue samples spanning the tongue, oesophagus, stomach, ileum, colon, liver, and pancreas examined Thymosin Beta 4 distribution across fetal and adult gastrointestinal tissue.

Distinct differences in reactivity between fetal and adult tissue were observed in several organs, contributing to basic research on this peptide's distribution across development.2

BPC-157 Cell-Based Signaling Research

BPC-157's proline-rich, conformationally constrained backbone, roughly a quarter of its fifteen residues, is studied as a structural basis for its resistance to enzymatic degradation relative to less rigid peptides of similar length.

In vitro studies using cultured cell models found that BPC-157 promotes cell proliferation, migration, and angiogenesis-related signaling within this cell-based system.3

Combined Research Applications

Both peptides have established, separately studied laboratory profiles, actin-sequestering and tissue-distribution research for Thymosin Beta 4, proliferation and migration signaling for BPC-157, that are examined together in this formulation as a single research platform.

Combined use of the two peptides remains an area of exploratory laboratory research, and available data on concurrent use is preliminary and not considered conclusive.

Analytical Verification for Blended Products

Given the substantial size difference between a 15-residue and a 43-residue peptide, researchers reviewing documentation for this blend are encouraged to confirm that HPLC or mass spectrometry data resolves BPC-157 and TB-500 as distinct peaks rather than reporting a single aggregate purity figure.

Storage and Handling in the Laboratory Setting

TB-500's single methionine residue makes it more susceptible to oxidative degradation than BPC-157's proline-rich backbone, giving the two peptides different sensitivities within the same vial.

The lyophilized blend is stored under sub-zero freezer conditions to preserve both components' integrity prior to use.

The LKKTET Motif

Within the 43-residue Thymosin Beta 4 sequence, positions 17 through 22 read Leu-Lys-Lys-Thr-Glu-Thr. That six-residue stretch, written LKKTET in single-letter code, is the segment most closely associated with actin binding in the research literature.

Its presence is one way to confirm that a preparation sold under the TB-500 name carries the complete sequence rather than a truncated construct. Reading positions 17 to 22 of the sequence in the specification table above locates the motif directly.

Two Peptides With Opposite Charge Characters

The components differ in charge as sharply as they differ in size. Thymosin Beta 4 carries eleven acidic residues, eight glutamates and three aspartates, against nine lysines, leaving it net negative near neutral pH.

Close to half of its residues are charged, which is unusual and contributes to the extended, largely unstructured conformation this peptide adopts in isolation. BPC-157 by contrast carries only four ionizable side chains across fifteen residues.

That difference in charge density, on top of the roughly threefold difference in mass, is what allows the two to resolve cleanly during chromatographic analysis.

The Acetylated N-Terminus

TB-500's sequence opens with an acetyl group rather than a free amine. This is not an added modification for synthetic convenience: Thymosin Beta 4 is acetylated at its N-terminus in its native form, so the capped version reproduces the natural structure rather than altering it.

The acetyl group removes the positive charge a free N-terminus would carry and blocks aminopeptidases that trim peptides from that end.

What TB-500 Refers To

The TB-500 designation is used in catalogs for both the complete 43-residue Thymosin Beta 4 sequence and, in some listings, for shorter fragments containing only the actin-binding region. The sequence in the specification table above is the full-length form.

This peptide also appears in published work as Thymosin Beta 4, Thymosin β4, and Tβ4. Confirming the residue count rather than relying on the TB-500 label is the reliable way to establish which form a given lot contains.

Important Notice

This product is intended solely for in vitro laboratory research and is not suitable for human consumption, diagnostic use, or therapeutic application. All handling must comply with institutional laboratory safety protocols and applicable research regulations, and these findings do not establish safety or efficacy in humans.

Product Information

The material is supplied as a lyophilized white powder. Each vial contains a total of 10 mg of peptide content, consisting of 5 mg of BPC-157 and 5 mg of Thymosin Beta 4 (TB500), intended strictly for in vitro laboratory research.

References

1. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multifunctional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.
2. Nemolato S, Cabras T, Cau F, et al. Different Thymosin Beta 4 Immunoreactivity in Foetal and Adult Gastrointestinal Tract. PLoS One. 2010;5(2):e9111.
3. Huang T et al. Body protective compound-157 promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther. 2015;9:2485-99.

Related Research products